ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Middle East Cancer Consortium Formed; Armitage, Mayer Elected To ASCO Positions

May 24, 1996

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

ACS-Roosevelt Awards Announced

June 22, 1979

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

UK Research Groups To Fund Virtual Tumor Bank

April 18, 2003

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002